Topic
preclinical-research
1 stories related to this topic, newest first.
manilatimes.netfinance48 days ago
Akari Therapeutics Stock Falls After 255 Percent Weekly Gain
Akari Therapeutics PLC shares declined on Tuesday following a 255 percent surge late last week. The movement came after the company reported preclinical results for its AKTX-101 asset in KRAS-mutated pancreatic cancer models.